FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616454883> ?p ?o ?g. }

• W2616454883 endingPage "579" @default.
• W2616454883 startingPage "577" @default.
• W2616454883 abstract "WHO treatment guidelines recommend efavirenz in first-line antiretroviral therapy (ART). Efavirenz commonly causes early transient neuropsychiatric adverse events. We present 20 cases with severe encephalopathy accompanied by ataxia due to efavirenz toxicity.Consecutive HIV-infected adults taking efavirenz-containing ART admitted to Tshepong hospital, Klerksdorp, South Africa with ataxia and encephalopathy were included in this case series.We identified 20 women admitted to hospital with severe ataxia. All received efavirenz-based ART for a median of 2 years. All had severe ataxia and none had nystagmus. Eleven had features of encephalopathy. Median weight was 34 kg [interquartile range (IQR): 29.7-35.3]; median CD4 count 299 cells/mm (IQR: 258-300) and most (18 of 19) were virally suppressed. Eight patients had a record of prior weights and 7 of 8 showed significant weight loss with a median weight loss of 10.8 kg (IQR: 8-11.6). All cases had plasma efavirenz assays, 19 were supratherapeutic (more than twice the upper level of therapeutic range), and 15 had concentrations above the upper limit of assay detection. Ataxia resolved after withdrawal of efavirenz at a median time of 2 months (IQR: 1.25-4) and recurred in 2 of 3 patients when rechallenged. Admissions before diagnosis were frequent with 10 cases admitted previously. Three women died.Efavirenz toxicity may present with severe reversible ataxia often with encephalopathy years after its initiation, likely in genetic slow metabolizers. We recommend that patients whose weight is <40 kg receive lower doses of efavirenz and that therapeutic drug monitoring be considered, and efavirenz stopped in patients presenting with ataxia. Eight patients had a record of prior subsequent weights and 7 of 8 showed significant weight loss gain; median gain of 10.8 kg (IQR: 8-11.6)." @default.
• W2616454883 created "2017-05-26" @default.
• W2616454883 creator A5019004675 @default.
• W2616454883 creator A5026136715 @default.
• W2616454883 creator A5034322602 @default.
• W2616454883 creator A5059101690 @default.
• W2616454883 creator A5080719777 @default.
• W2616454883 creator A5083468573 @default.
• W2616454883 creator A5083669339 @default.
• W2616454883 creator A5084512964 @default.
• W2616454883 date "2017-08-15" @default.
• W2616454883 modified "2023-10-03" @default.
• W2616454883 title "Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series" @default.
• W2616454883 cites W1552315577 @default.
• W2616454883 cites W173494530 @default.
• W2616454883 cites W1967951091 @default.
• W2616454883 cites W2011912864 @default.
• W2616454883 cites W2014191329 @default.
• W2616454883 cites W2032623485 @default.
• W2616454883 cites W2045229224 @default.
• W2616454883 cites W2050781209 @default.
• W2616454883 cites W2058207881 @default.
• W2616454883 cites W2071086973 @default.
• W2616454883 cites W2072553005 @default.
• W2616454883 cites W2077210334 @default.
• W2616454883 cites W2099746597 @default.
• W2616454883 cites W2133451349 @default.
• W2616454883 cites W2136617531 @default.
• W2616454883 cites W2162859654 @default.
• W2616454883 cites W2759906275 @default.
• W2616454883 doi "https://doi.org/10.1097/qai.0000000000001451" @default.
• W2616454883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5532735" @default.
• W2616454883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28520619" @default.
• W2616454883 hasPublicationYear "2017" @default.
• W2616454883 type Work @default.
• W2616454883 sameAs 2616454883 @default.
• W2616454883 citedByCount "16" @default.
• W2616454883 countsByYear W26164548832017 @default.
• W2616454883 countsByYear W26164548832018 @default.
• W2616454883 countsByYear W26164548832019 @default.
• W2616454883 countsByYear W26164548832020 @default.
• W2616454883 countsByYear W26164548832021 @default.
• W2616454883 countsByYear W26164548832022 @default.
• W2616454883 countsByYear W26164548832023 @default.
• W2616454883 crossrefType "journal-article" @default.
• W2616454883 hasAuthorship W2616454883A5019004675 @default.
• W2616454883 hasAuthorship W2616454883A5026136715 @default.
• W2616454883 hasAuthorship W2616454883A5034322602 @default.
• W2616454883 hasAuthorship W2616454883A5059101690 @default.
• W2616454883 hasAuthorship W2616454883A5080719777 @default.
• W2616454883 hasAuthorship W2616454883A5083468573 @default.
• W2616454883 hasAuthorship W2616454883A5083669339 @default.
• W2616454883 hasAuthorship W2616454883A5084512964 @default.
• W2616454883 hasBestOaLocation W26164548832 @default.
• W2616454883 hasConcept C118552586 @default.
• W2616454883 hasConcept C119060515 @default.
• W2616454883 hasConcept C126322002 @default.
• W2616454883 hasConcept C141071460 @default.
• W2616454883 hasConcept C142462285 @default.
• W2616454883 hasConcept C159047783 @default.
• W2616454883 hasConcept C187212893 @default.
• W2616454883 hasConcept C197934379 @default.
• W2616454883 hasConcept C2778186239 @default.
• W2616454883 hasConcept C2778337148 @default.
• W2616454883 hasConcept C2778621155 @default.
• W2616454883 hasConcept C2780906641 @default.
• W2616454883 hasConcept C2781432083 @default.
• W2616454883 hasConcept C2993143319 @default.
• W2616454883 hasConcept C3013748606 @default.
• W2616454883 hasConcept C42219234 @default.
• W2616454883 hasConcept C71924100 @default.
• W2616454883 hasConcept C90924648 @default.
• W2616454883 hasConceptScore W2616454883C118552586 @default.
• W2616454883 hasConceptScore W2616454883C119060515 @default.
• W2616454883 hasConceptScore W2616454883C126322002 @default.
• W2616454883 hasConceptScore W2616454883C141071460 @default.
• W2616454883 hasConceptScore W2616454883C142462285 @default.
• W2616454883 hasConceptScore W2616454883C159047783 @default.
• W2616454883 hasConceptScore W2616454883C187212893 @default.
• W2616454883 hasConceptScore W2616454883C197934379 @default.
• W2616454883 hasConceptScore W2616454883C2778186239 @default.
• W2616454883 hasConceptScore W2616454883C2778337148 @default.
• W2616454883 hasConceptScore W2616454883C2778621155 @default.
• W2616454883 hasConceptScore W2616454883C2780906641 @default.
• W2616454883 hasConceptScore W2616454883C2781432083 @default.
• W2616454883 hasConceptScore W2616454883C2993143319 @default.
• W2616454883 hasConceptScore W2616454883C3013748606 @default.
• W2616454883 hasConceptScore W2616454883C42219234 @default.
• W2616454883 hasConceptScore W2616454883C71924100 @default.
• W2616454883 hasConceptScore W2616454883C90924648 @default.
• W2616454883 hasIssue "5" @default.
• W2616454883 hasLocation W26164548831 @default.
• W2616454883 hasLocation W26164548832 @default.
• W2616454883 hasLocation W26164548833 @default.
• W2616454883 hasLocation W26164548834 @default.
• W2616454883 hasOpenAccess W2616454883 @default.
• W2616454883 hasPrimaryLocation W26164548831 @default.
• W2616454883 hasRelatedWork W168234803 @default.

• next